Skip to main content
SpringerLink
Log in

Constipation-Predominant Irritable Bowel Syndrome

  • Chapter
Constipation

  • 1331 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Drossman DA, Corazziari E, Talley NJ, et al. Rome II: a multinational consensus document on functional gastrointestinal disorders. Gut 1999;45:1–81.

    Article  Google Scholar 

  2. Ehrenpreis ED, Burns EA, Hofmann C. The AFP Guide to Diagnosis and Management of the Irritable Bowel Syndrome. Lisle, IL: Illinois Academy of Family Physicians Press, 2003.

    Google Scholar 

  3. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97(11 suppl):S1–5.

    Google Scholar 

  4. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable syndrome. Gastroenterology 2002;123(6):2108–2131.

    Article  PubMed  Google Scholar 

  5. Mearin F, Balboa A, Badia X, et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003;15:165–172.

    Article  PubMed  Google Scholar 

  6. Drossman D, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569–1580.

    Article  PubMed  CAS  Google Scholar 

  7. Coulie B, Camilleri M. Irritable bowel syndrome. Clin Perspect Gastroenterol 1999;2:329–338.

    Google Scholar 

  8. Camilleri M, Williams DE. Economic burden of irritable bowel syndrome reappraised with strategies to control expenditures. Pharmacoeconomic 2000;4:331–338.

    Article  Google Scholar 

  9. Zuckerman M, Guerra L, Drossman D, Foland J, Gregory G. Health-care-seeking behaviors related to bowel complaints: Hispanics versus non-Hispanic whites. Dig Dis Sci 1996;41:77–82.

    Article  PubMed  CAS  Google Scholar 

  10. Kalantar JS, Locke GR, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut 2003;52(12):1703–1707.

    Article  PubMed  CAS  Google Scholar 

  11. El-Serag HB, Olden K, Bjorkman D. Health related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16(6):1171–1185.

    Article  PubMed  CAS  Google Scholar 

  12. Halder SL, Locke GR, Talley NJ, Fett SL, Zinmeister AR, Melton LJ. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004;19(2):233–242.

    Article  PubMed  CAS  Google Scholar 

  13. Gralnek I, Hays R, Kilbourne A, Naliboff, B, Mayer E. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654–660.

    Article  PubMed  CAS  Google Scholar 

  14. Aziz Q, Thompson D. Brain-gut axis in health and disease. Gastroenterology 1998;114:559–578.

    Article  PubMed  CAS  Google Scholar 

  15. Thompson W, Longsreth G, Drossman D, et al. Irritable bowel syndrome. In: Drossman D, ed. The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates, 2000.

    Google Scholar 

  16. Rao S. Visceral hyperalgia: the key for unraveling functional gastrointestinal disorders. Dig Dis 1996;14:271–275.

    Article  PubMed  CAS  Google Scholar 

  17. Mertz H, Naliboff B, Munakata J, Niazi N. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40–52.

    Article  PubMed  CAS  Google Scholar 

  18. Kellow J, Eckersley C, Jones M. Enhanced perception of physiological motility in the irritable bowel syndrome. Gastroenterology 1991;101:1621–1627.

    PubMed  CAS  Google Scholar 

  19. Silverman D, Munakata J, Ennes H, et al. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997;112:64–72.

    Article  PubMed  CAS  Google Scholar 

  20. Garcia-Rodriguez l, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 1999;318:565–566.

    Google Scholar 

  21. McKendrick M, Read N. Irritable bowel syndrome post Salmonella infection. J Infect 1994;29:1–3.

    Article  PubMed  CAS  Google Scholar 

  22. Neal K, Hebdon J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome. Br J Med 1997;314:779–782.

    CAS  Google Scholar 

  23. Gwee K, Collins S, Read N, et al. Increased rectal mucosal expression of interleukin-1 beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003;52:523–526.

    Article  PubMed  CAS  Google Scholar 

  24. Barbara G, Stanghellini V, DeGiorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126(3):693–702.

    Article  PubMed  Google Scholar 

  25. AGA Patient Care Committee. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997;112:2120–2137.

    Article  Google Scholar 

  26. Drossman D, Leserman J, Nachman, LiZ. Sexual and physical abuse in women with functional or organic gastrointestinal illnesses. Ann Intern Med 1990;113:828–833.

    PubMed  CAS  Google Scholar 

  27. Shen B, Soffer E. The challenge of irritable bowel syndrome: creating an alliance between patient and physician. Cleve Clin J Med 2001;68:229–233.

    Google Scholar 

  28. Bearcroft C, Perrett D, Farthing M. Postprandial plasma 5-hydroxytryptamine in diarrhea predominant irritable bowel syndrome: a pilot study. Gut 1998;42:42–46.

    Article  PubMed  CAS  Google Scholar 

  29. Ahn J, Ehrenpreis ED. Emerging treatments for irritable bowel syndrome. Expert Opin Pharmacother 2001;3(1):9–21.

    Article  Google Scholar 

  30. Nanda R, James R, Smith H, Dudley C, Jewell D. Food intolerance and the irritable bowel syndrome. Gut 1989;30:1099–1104.

    PubMed  CAS  Google Scholar 

  31. Ehrenpreis E. Lactose intolerance: definition, clinical features, and treatment. Practical Gastroenterol 1999;23:15–19.

    Google Scholar 

  32. Brown S, Cann P, Read NW. Effects of coffee on distal colon function. Gut 1990;31:450–453.

    PubMed  CAS  Google Scholar 

  33. Camillari M. Review article: clinical evidence to support current therapies of irritable bowel syndrome. Aliment Pharmacol Ther 1999;13:48–53.

    Article  Google Scholar 

  34. DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000;95(2):446–450.

    Article  PubMed  CAS  Google Scholar 

  35. Camilleri M. Review article: tegaserod. Aliment Pharmacol Ther 2001;15:277–289.

    Article  PubMed  CAS  Google Scholar 

  36. Grider J, Fox-Orenstein A, Jin J. 5-Hydroxytryptamine receptor agonists initiate the peristaltic reflex in human, rat and guinea pig intestine. Gastroenterology 1998;115:370–380.

    Article  PubMed  CAS  Google Scholar 

  37. Tegaserod maleate (Zelnorm) for IBS with constipation. Med Lett Drugs Ther 2002;44(1139):79–80.

    Google Scholar 

  38. Otten M, Schneider H, Wurzer H, et al. A double-blind, placebo-controlled evaluation of safety and efficacy of 12 week, twice-daily treatment with prucalopride in patients with chronic constipation. Gastroenterology 1999;116:A1043.

    Article  Google Scholar 

  39. Novick J, Miner P, Krause R, et al. A randomized, double-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002;16:1877–1888.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Rush Presbyterian St. Luke’s Medical Center, Arlington Heights, IL, USA

    Eli D. Ehrenpreis MD (Adult Care Specialists)

Authors
  1. Eli D. Ehrenpreis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cleveland Clinic Florida, Weston, FL, USA

    Steven D. Wexner MD, FACS, FRCS, FRCS (Ed) (21st Century Oncology Chair in Colorectal Surgery Chairman, Department of Colorectal Surgery Chief of Staff, Professor of Surgery and Clinical Professor of Surgery) (21st Century Oncology Chair in Colorectal Surgery Chairman, Department of Colorectal Surgery Chief of Staff, Professor of Surgery and Clinical Professor of Surgery)

  2. Ohio State University Health Sciences Center at the Cleveland Clinic Foundation, Columbus, OH, USA

    Steven D. Wexner MD, FACS, FRCS, FRCS (Ed) (21st Century Oncology Chair in Colorectal Surgery Chairman, Department of Colorectal Surgery Chief of Staff, Professor of Surgery and Clinical Professor of Surgery) (21st Century Oncology Chair in Colorectal Surgery Chairman, Department of Colorectal Surgery Chief of Staff, Professor of Surgery and Clinical Professor of Surgery)

  3. University of South Florida College of Medicine, Tampa, FL, USA

    Steven D. Wexner MD, FACS, FRCS, FRCS (Ed) (21st Century Oncology Chair in Colorectal Surgery Chairman, Department of Colorectal Surgery Chief of Staff, Professor of Surgery and Clinical Professor of Surgery) (21st Century Oncology Chair in Colorectal Surgery Chairman, Department of Colorectal Surgery Chief of Staff, Professor of Surgery and Clinical Professor of Surgery)

  4. Charles E. Schmitt College of Science, Florida Atlantic University, Boca Raton, FL, USA

    Steven D. Wexner MD, FACS, FRCS, FRCS (Ed) (21st Century Oncology Chair in Colorectal Surgery Chairman, Department of Colorectal Surgery Chief of Staff, Professor of Surgery and Clinical Professor of Surgery) (21st Century Oncology Chair in Colorectal Surgery Chairman, Department of Colorectal Surgery Chief of Staff, Professor of Surgery and Clinical Professor of Surgery)

  5. University of Hull, Cattingham, UK

    Graeme S. Duthie MD, FRCS, FRCSEd (Reader in Surgery and Honorary Consultant Colorectal Surgeon) (Reader in Surgery and Honorary Consultant Colorectal Surgeon)

  6. Hull and East Yorkshire NHS Trust, Castle Hill Hospital, Cottingham, UK

    Graeme S. Duthie MD, FRCS, FRCSEd (Reader in Surgery and Honorary Consultant Colorectal Surgeon) (Reader in Surgery and Honorary Consultant Colorectal Surgeon)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Ehrenpreis, E.D. (2006). Constipation-Predominant Irritable Bowel Syndrome. In: Wexner, S.D., Duthie, G.S. (eds) Constipation. Springer, London. https://doi.org/10.1007/978-1-84628-275-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-275-1_6

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-724-7

  • Online ISBN: 978-1-84628-275-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation